ClinicalTrials.govpublic full text
Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)
transcatheter aortic valve replacemen, angiotensin-converting enzyme inhibitors, cardiovascular events, ventricular remodeling, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967892
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.